GLP1R and synucleinopathy: For example, a recent study showed in a similar model of synucleinopathy that blocking A1 astrocyte conversion by microglia using glucagon-like peptide-1 receptor (GLP1R) agonists is neuroprotective, supporting a role of the innate immune system [58].